IlluminOss Medical produces minimally invasive conforming orthopedic implants leveraging it’s proprietary bone stabilization technology, the IlluminOss System. Through the unique combination of balloons, light activated monomers and flexible catheters, IlluminOss has created the world’s first patient conforming intramedullary implant. The IlluminOss system has been safely and effectively used worldwide in thousands of patients since 2010 for a wide variety of clinical indications.
IlluminOss provides the world’s first minimally invasive, patient conforming polymer implant for fracture repair and stabilization. The IlluminOss System incorporates a PET or Dacron® balloon catheter that is delivered through a small pathway into the intramedullary canal transiting the fracture site. Using a standard syringe, IlluminOss’ light activated, biocompatible monomer is infused into the balloon, causing it to expand, fill and conform to the patients intramedullary canal. Only upon the activation of IlluminOss’ visible light source will the monomer infused balloon begin to cure. The cured implant provides both longitudinal strength and rotational stability to allow for fracture repair and stabilization. Should ancillary fixation devices be needed they can be placed anywhere along the implant.
Balloon Angioplasty Catheter
Light Cured Liquid Monomer Similar to Dental Cement
Minimally Invasive Patient Conforming Orthopedic Implant
The IlluminOss System Components: Balloon Catheter
IlluminOss Photodynamic Liquid Monomer
Photodynamic Curing System
The IlluminOss System offers significant advantages to surgeons for treating a variety of fractures.
Significant Patient benefits may include:
In the U.S.A. the IlluminOss Photodynamic Bone Stabilization System is indicated for use in skeletally mature patients in the treatment of traumatic, fragility, pathological, and impending pathological fractures of the humerus, radius, and ulna. The IlluminOss Photodynamic Bone Stabilization System can also be used in conjunction with an FDA-cleared fracture fixaton system to provide supplemental fixation in the humerus, radius, and ulna.
Internationally the IlluminOss System is CE marked approved for use in the treatment fractures of light to low load bearing bones as well as in the humerus for the treatment of actual and impending pathologic fractures of the humerus associated with metastatic disease.
For a complete list of contraindications, warnings, risks and precautions refer to the implant instructions for use, surgical technique guide or contact your IlluminOss Medical sales representative.